candesartan

tumor necrosis factor ; Homo sapiens







11 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33380704 A comparative study on the anti-inflammatory effect of angiotensin-receptor blockers & statins on rheumatoid arthritis disease activity. 2020 Oct 1
2 31038541 Candesartan inhibits inflammation through an angiotensin II type 1 receptor independent way in human embryonic kidney epithelial cells. 2019 5
3 30521476 Beneficial effects of combined therapy with lacidipine and candesartan in obese hypertensive patients. 2018 Dec 1 1
4 25222109 Possible roles of tumor necrosis factor-α and angiotensin II type 1 receptor on high glucose-induced damage in renal proximal tubular cells. 2015 Feb 1
5 22155764 Assessment of enzymatic prodrug stability in human, dog and simulated intestinal fluids. 2012 Apr 1
6 20353766 Angiotensin II type 1 receptor blockers prevent tumor necrosis factor-alpha-mediated endothelial nitric oxide synthase reduction and superoxide production in human umbilical vein endothelial cells. 2010 Jun 25 1
7 18495130 Candesartan inhibits Toll-like receptor expression and activity both in vitro and in vivo. 2009 Jan 1
8 19730394 Candesartan reduces the innate immune response to lipopolysaccharide in human monocytes. 2009 Dec 1
9 16888237 Blockade of angiotensin II receptors reduces the expression of receptors for advanced glycation end products in human endothelial cells. 2006 Oct 1
10 14644777 Angiotensin II-induced MMP-2 release from endothelial cells is mediated by TNF-alpha. 2004 Apr 1
11 12957441 Pleiotropic effects of angiotensin II receptor blocker in hypertensive patients. 2003 Sep 3 1